Skip to main content
DAQING HUAKE CO.,LTD logo

DAQING HUAKE CO.,LTD — Investor Relations & Filings

Ticker · 000985 ISIN · CNE000001402 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,324 across all filing types
Latest filing 2024-04-26 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000985

About DAQING HUAKE CO.,LTD

https://www.huake.com

Daqing Huake Co., Ltd. specializes in the deep processing of petrochemical products and the production of fine chemicals. The company's core business activities involve the research, development, manufacturing, and distribution of a diverse range of chemical materials. Key product lines include C5 and C9 petroleum resins, which are widely used in adhesives, coatings, and rubber compounding. Additionally, the company produces high-purity acetonitrile, isopropyl alcohol, and polypropylene. Daqing Huake leverages its proximity to major oil and gas resources to maintain a stable supply chain and focuses on technological innovation to enhance product quality. Its products serve various industrial sectors, including plastics, pharmaceuticals, and chemical synthesis, catering to both domestic and international markets.

Recent filings

Filing Released Lang Actions
年度关联方资金占用专项审计报告
Audit Report / Information Classification · 95% confidence The document is a specialized audit report focusing on non-operating fund occupation and other related party fund transactions for the fiscal year 2023. It includes an audit opinion from a registered accounting firm, references to specific regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and detailed financial tables summarizing the fund occupation and related party transactions. The document is not a full annual report but a standalone audit report on a specific financial aspect, with detailed audit scope, management responsibilities, and auditor conclusions. It is not an announcement or a brief summary but a substantive audit report. Therefore, it fits the category of Audit Report / Information (AR).
2024-04-26 Chinese
董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the company's ninth board of directors meeting, including reports and proposals that will be submitted to the shareholders' meeting. It includes voting results on various reports such as the general manager's work report, board work report, independent directors' report, internal control self-evaluation report, profit distribution plan, and others. It also mentions the approval of the 2023 annual report and 2024 first quarter report to be submitted to the shareholders. The document is not the reports themselves but a formal announcement of the board meeting decisions and resolutions. The document length is 3522 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement of board meeting resolutions and related information, not the actual reports or financial statements themselves.
2024-04-26 Chinese
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2023 by 大庆华科股份有限公司. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2023, including financial and non-financial internal control deficiencies, standards for defect recognition, and corrective actions. The content is focused on internal control assessment rather than a full annual report or audit report. It is a detailed report on internal control evaluation, which aligns with the definition of an Audit Report / Information (AR) as it relates to internal control results and applied standards. The document length is 3342 characters, which is sufficient for a report rather than a brief announcement. Therefore, the classification is AR with high confidence.
2024-04-26 Chinese
大庆华科股份有限公司监事会审核意见
Audit Report / Information Classification · 95% confidence The document is a supervisory board's review and opinion on the company's 2023 annual report, 2024 first quarter report, and 2023 internal control self-evaluation report. It confirms the procedures and contents of these reports comply with laws and regulations and are accurate and complete. The document itself is a review or audit opinion rather than the full annual report or quarterly report. It is short (732 characters) and does not contain detailed financial data or the full reports. Therefore, it is not the Annual Report (10-K) or Interim Report (IR) itself, but rather an Audit Report / Information (AR) type document, which includes audit opinions and internal control evaluations.
2024-04-26 Chinese
大庆华科股份有限公司2023年度独立董事述职报告（王涌）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report for the year 2023" for a company. It details the independent director's duties, attendance at meetings, communication with auditors, and overall evaluation of their role during the year. The content focuses on governance, compliance with laws and regulations, and the director's oversight activities rather than financial results or audit opinions. It does not contain financial statements or audit reports, nor is it a brief announcement or a presentation. The document is a detailed report on board/management information specifically related to the independent director's role and activities. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is 2596 characters, which is sufficient for a detailed report but not a full annual or interim report. Hence, the classification is MANG with high confidence.
2024-04-26 Chinese
大庆华科股份有限公司关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policies by the company, referencing a new accounting standard issued by the Ministry of Finance of China. It explicitly states that the change does not require board or shareholder approval and does not affect financial results. The document is short (812 characters) and serves as a formal notice rather than a full financial report or audit. It does not contain financial statements or detailed financial analysis. This type of document is best classified as a Regulatory Filing (RNS) because it is a compliance announcement about accounting policy changes without substantive financial data or report content.
2024-04-26 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.